BR112018000194A2 - sistema de vetor de adenovírus 9 de ave (fadv-9) e métodos associados - Google Patents

sistema de vetor de adenovírus 9 de ave (fadv-9) e métodos associados

Info

Publication number
BR112018000194A2
BR112018000194A2 BR112018000194A BR112018000194A BR112018000194A2 BR 112018000194 A2 BR112018000194 A2 BR 112018000194A2 BR 112018000194 A BR112018000194 A BR 112018000194A BR 112018000194 A BR112018000194 A BR 112018000194A BR 112018000194 A2 BR112018000194 A2 BR 112018000194A2
Authority
BR
Brazil
Prior art keywords
fadv
vectors
associated methods
vector system
recombinant
Prior art date
Application number
BR112018000194A
Other languages
English (en)
Inventor
Pei Yanlong
Ackford James
Carlos CORREDOR Juan
J. KRELL Peter
Nagy Éva
Original Assignee
University Of Guelph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Guelph filed Critical University Of Guelph
Publication of BR112018000194A2 publication Critical patent/BR112018000194A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10211—Aviadenovirus, e.g. fowl adenovirus A
    • C12N2710/10241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/48—Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

a presente invenção refere-se aos vetores virais recombinantes obti-dos a partir de adenovírus 9 de ave (fadv-9) e métodos associados. os vetores fadv-9 recombinantes podem incluir uma ou mais dele-ções na extremidade esquerda e/ou na extremidade direita do genoma de fadv-9. opcionalmente, os vetores incluem uma ou mais sequências de nucleotídeos exógenas, uma tal sequência codificando um polipeptídeo de interesse. os vetores fadv-9 recombinantes podem ser usados como um vetor de entrega dual. é também descrito o uso dos vetores para a geração de uma resposta imunogênica em um indivíduo e/ou para a prevenção de doença.
BR112018000194A 2015-07-10 2016-07-11 sistema de vetor de adenovírus 9 de ave (fadv-9) e métodos associados BR112018000194A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562190913P 2015-07-10 2015-07-10
PCT/CA2016/050811 WO2017008154A1 (en) 2015-07-10 2016-07-11 Fowl adenovirus 9 (fadv-9) vector system and associated methods

Publications (1)

Publication Number Publication Date
BR112018000194A2 true BR112018000194A2 (pt) 2018-09-11

Family

ID=57756612

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018000194A BR112018000194A2 (pt) 2015-07-10 2016-07-11 sistema de vetor de adenovírus 9 de ave (fadv-9) e métodos associados

Country Status (11)

Country Link
US (2) US20190153470A1 (pt)
EP (1) EP3320100A4 (pt)
BR (1) BR112018000194A2 (pt)
CA (1) CA2991925A1 (pt)
CO (1) CO2018001339A2 (pt)
EA (1) EA201890274A1 (pt)
IL (1) IL256801B (pt)
MX (1) MX2018000353A (pt)
PE (1) PE20181087A1 (pt)
WO (1) WO2017008154A1 (pt)
ZA (1) ZA201800705B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016020730A1 (es) * 2014-08-08 2016-02-11 Laboratorio Avi-Mex, S.A. De C.V. Vacuna en vector recombinante de adenovirus aviar serotipo 9
CA3173714A1 (en) * 2020-03-29 2021-10-07 Uwe D. Staerz Replication-deficient avian adenoviral vectors, their design and uses
CN112094824B (zh) * 2020-08-19 2021-04-20 湖北省农业科学院畜牧兽医研究所 表达禽腺病毒4型截短Fiber2蛋白的重组新城疫病毒耐热疫苗株及其制备方法与应用
CN113584231B (zh) * 2021-09-10 2024-04-19 广西壮族自治区兽医研究所 鉴定i群禽腺病毒血清8型的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6296852B1 (en) * 1993-04-14 2001-10-02 Commonwealth Scientific And Industrial Research Organisation Recombinant avian adenovirus vector
DE19615803A1 (de) * 1996-04-20 1997-10-23 Boehringer Ingelheim Int CELO-Virus
US6841158B1 (en) * 1998-09-22 2005-01-11 Boehringer Ingelheim International Gmbh Recombinant celo virus and celo virus DNA
JP2012509308A (ja) * 2008-11-19 2012-04-19 ラボラトリオ アヴィメキシコ エスエー ディーイー シーヴィー 遺伝子組み換え不活性化ウィルスベクターワクチン

Also Published As

Publication number Publication date
IL256801A (en) 2018-03-29
ZA201800705B (en) 2018-12-19
CA2991925A1 (en) 2017-01-19
EP3320100A4 (en) 2018-12-26
WO2017008154A1 (en) 2017-01-19
US20190153470A1 (en) 2019-05-23
IL256801B (en) 2021-10-31
US20210317476A1 (en) 2021-10-14
PE20181087A1 (es) 2018-07-09
EA201890274A1 (ru) 2018-08-31
EP3320100A1 (en) 2018-05-16
CO2018001339A2 (es) 2018-04-30
MX2018000353A (es) 2018-03-14

Similar Documents

Publication Publication Date Title
CL2019002280A1 (es) Vectores virales, adenovirales y composiciones a base de una secuencia de ornitina transcarbamilasa humana (hotch) modificada genéticamente y su uso en el tratamiento de deficiencia de la otc. (divisional solicitud 201602235)
PH12019501130A1 (en) Viral delivery of neoantigens
SA517390590B1 (ar) Ix عامل معدل، وتركيبات وطرق واستخدامات لنقل الجين إلى الخلايا، والأعضاء والأنسجة
BR112018000194A2 (pt) sistema de vetor de adenovírus 9 de ave (fadv-9) e métodos associados
BR112019024813A2 (pt) adenovírus recombinantes portando transgenes
BR112017017867A2 (pt) métodos e composições para tratamento de doenças oculares genéticas
SG10201901482XA (en) Oncolytic adenovirus encoding a b7 protein
BR112015021884A2 (pt) vetores compreendendo sequências de polinucleotídeos de stuffer/agente de enchimento e métodos de uso
EA201692359A1 (ru) Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса
AR097762A1 (es) Formulaciones secas de vacunas que son estables a temperatura ambiente
MX2016017382A (es) Metodos para preparar analogos de nucleotido sustituidos.
MX2021004397A (es) Vectores aav recombinantes que expresan genes osteoprotectores, que incluyen has2 y lubricina, de utilidad en el tratamiento de la osteoartritis y afecciones articulares relacionadas en mamiferos.
BR112018067536A2 (pt) sistema de transpóson e métodos de uso
MX2022006602A (es) Vacunas de herpesvirus de pavo recombinante y uso de las mismas.
BR112013030824A8 (pt) Bactéria gram-positiva, ácido necleico recombinante, composição farmacêutica e vetor
MX2021014525A (es) Adenovirus modificados.
MX2019008105A (es) Virus.
PH12017500216B1 (en) Vaccine in serotype-9 fowl adenovirus recombinant vector
BR112016026842A2 (pt) preparação compreendendo fator viii e peptídeos de fator de von willebrand
MX366836B (es) Celulas aviares para la produccion mejorada de virus.
AR108014A1 (es) Vacuna universal para enfermedades virales y método de vacunación
BR112018003580A2 (pt) molécula de ácido nucléico, método para apresentar um polipeptídeo alvo, proteína recombinante, partícula do tipo viral, composição farmacêutica, polipeptídeo, vetor, célula hospedeira e método para preparar a proteína recombinante
ES2689797T3 (es) Vacuna de virus Sendai modificado y vector para la obtención de imágenes
MX2019007924A (es) Vacunas contra la influenza.
EA202090628A1 (ru) Система экспрессии paramyxoviridae

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]